Mode selection for positive airway pressure titration in adult patients with central sleep apnea syndromes
- Tomasz J Kuzniar, MD, PhD, FCCP, FAASM
Tomasz J Kuzniar, MD, PhD, FCCP, FAASM
- Assistant Professor of Medicine
- NorthShore University HealthSystem, University of Chicago
- Neil Freedman, MD
Neil Freedman, MD
- Head, Division of Pulmonary, Critical Care, Allergy and Immunology
- North Shore University Health System
Positive airway pressure (PAP) is used to treat sleep-disordered breathing in patients with central sleep apnea (CSA) and hypoventilation syndromes. Determining the optimal pressure settings is of paramount importance to eliminate apneas and to help assure patient adherence to therapy.
Selecting a titration method to determine the optimal pressure in patients with CSA is discussed in this topic. An overview of the treatment of CSA, selection of a titration method for patients with obstructive sleep apnea, and PAP therapy for hypoventilation syndromes are discussed separately. (See "Central sleep apnea: Treatment" and "Types of noninvasive nocturnal ventilatory support in neuromuscular and chest wall disease" and "Continuous noninvasive ventilatory support for patients with respiratory muscle dysfunction" and "Noninvasive positive airway pressure therapy of the obesity hypoventilation syndrome".)
DIAGNOSIS AND CAUSES OF CENTRAL SLEEP APNEA (CSA)
Central sleep apnea (CSA) syndromes are characterized by the absence of both airflow and ventilatory effort during sleep. CSA is usually best diagnosed during an attended in-laboratory polysomnographic (PSG)-based sleep test but can occasionally be diagnosed on a home sleep apnea test (HSAT). (See "Central sleep apnea: Risk factors, clinical presentation, and diagnosis", section on 'Diagnostic evaluation'.)
CSA can be primary (ie, idiopathic CSA) or secondary to other conditions (Cheyne-Stokes breathing, medical conditions such as stroke or heart failure, suppressant drug or substance use, high altitude periodic breathing, or treatment-emergent central sleep apnea). Alternatively, CSA can be classified as hyperventilation-related (eg, Cheyne-Stokes breathing, primary CSA) or hypoventilation-related (eg, central nervous system diseases, drugs or substances) (table 1). There is also a subset of conditions primarily associated with alveolar hypoventilation (neuromuscular diseases, severe thoracic cage disorders such as kyphoscoliosis) in which central sleep apneas or hypopneas may be present. In many of these conditions, central apnea is not the only or even dominant type of sleep-disordered breathing that is present. It is therefore prudent that the clinician be aware of the proportional spectrum of sleep-disordered breathing type in a given patient such that an appropriate modality targeted at the major type of sleep-disordered breathing is chosen. (See "Polysomnography in the evaluation of sleep-disordered breathing in adults".)
Hypoventilation syndromes without apneic events may be central (eg, spinal cord injury) or peripheral (eg, myasthenia gravis), and when severe enough may be treated with noninvasive positive airway pressure (PAP), the details of which are discussed separately. (See 'Patients with central hypoventilation syndromes' below and "Respiratory muscle weakness due to neuromuscular disease: Clinical manifestations and evaluation".)
Subscribers log in hereLiterature review current through: Jul 2017. | This topic last updated: May 17, 2016.References
- Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365:1046.
- Punjabi NM, Caffo BS, Goodwin JL, et al. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med 2009; 6:e1000132.
- Arzt M, Floras JS, Logan AG, et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation 2007; 115:3173.
- Gilmartin GS, Daly RW, Thomas RJ. Recognition and management of complex sleep-disordered breathing. Curr Opin Pulm Med 2005; 11:485.
- Hamilton RD, Winning AJ, Horner RL, Guz A. The effect of lung inflation on breathing in man during wakefulness and sleep. Respir Physiol 1988; 73:145.
- Pépin JL, Pajon A, Veale D, et al. Central sleep apnoea syndrome with upper airway collapse. Eur Respir J 1993; 6:592.
- Badr MS, Toiber F, Skatrud JB, Dempsey J. Pharyngeal narrowing/occlusion during central sleep apnea. J Appl Physiol (1985) 1995; 78:1806.
- Harms CA, Zeng YJ, Smith CA, et al. Negative pressure-induced deformation of the upper airway causes central apnea in awake and sleeping dogs. J Appl Physiol (1985) 1996; 80:1528.
- Javaheri S, Winslow D, McCullough P, et al. The Use of a Fully Automated Automatic Adaptive Servoventilation Algorithm in the Acute and Long-term Treatment of Central Sleep Apnea. Chest 2015; 148:1454.
- Morgenthaler TI, Kuzniar TJ, Wolfe LF, et al. The complex sleep apnea resolution study: a prospective randomized controlled trial of continuous positive airway pressure versus adaptive servoventilation therapy. Sleep 2014; 37:927.
- Correia S, Martins V, Sousa L, et al. Clinical impact of adaptive servoventilation compared to other ventilatory modes in patients with treatment-emergent sleep apnea, central sleep apnea and Cheyne-Stokes respiration. Rev Port Pneumol (2006) 2015; 21:132.
- Shapiro CM, Chung SA, Wylie PE, et al. Home-use servo-ventilation therapy in chronic pain patients with central sleep apnea: initial and 3-month follow-up. Sleep Breath 2015; 19:1285.
- Chowdhuri S, Ghabsha A, Sinha P, et al. Treatment of central sleep apnea in U.S. veterans. J Clin Sleep Med 2012; 8:555.
- Cowie MR, Woehrle H, Wegscheider K, et al. Adaptive Servo-Ventilation for Central Sleep Apnea in Systolic Heart Failure. N Engl J Med 2015; 373:1095.
- Bradley TD, Logan AG, Kimoff RJ, et al. Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med 2005; 353:2025.
- Krachman SL, Crocetti J, Berger TJ, et al. Effects of nasal continuous positive airway pressure on oxygen body stores in patients with Cheyne-Stokes respiration and congestive heart failure. Chest 2003; 123:59.
- Randerath WJ, Nothofer G, Priegnitz C, et al. Long-term auto-servoventilation or constant positive pressure in heart failure and coexisting central with obstructive sleep apnea. Chest 2012; 142:440.
- Kuzniar TJ, Golbin JM, Morgenthaler TI. Moving beyond empiric continuous positive airway pressure (CPAP) trials for central sleep apnea: a multi-modality titration study. Sleep Breath 2007; 11:259.
- Kasai T, Narui K, Dohi T, et al. Efficacy of nasal bi-level positive airway pressure in congestive heart failure patients with cheyne-stokes respiration and central sleep apnea. Circ J 2005; 69:913.
- Aurora RN, Chowdhuri S, Ramar K, et al. The treatment of central sleep apnea syndromes in adults: practice parameters with an evidence-based literature review and meta-analyses. Sleep 2012; 35:17.
- Morgenthaler TI, Gay PC, Gordon N, Brown LK. Adaptive servoventilation versus noninvasive positive pressure ventilation for central, mixed, and complex sleep apnea syndromes. Sleep 2007; 30:468.
- Aurora RN, Bista SR, Casey KR, et al. Updated Adaptive Servo-Ventilation Recommendations for the 2012 AASM Guideline: "The Treatment of Central Sleep Apnea Syndromes in Adults: Practice Parameters with an Evidence-Based Literature Review and Meta-Analyses". J Clin Sleep Med 2016; 12:757.
- Javaheri S, Brown LK, Randerath WJ. Clinical applications of adaptive servoventilation devices: part 2. Chest 2014; 146:858.
- Javaheri S, Brown LK, Randerath WJ. Positive airway pressure therapy with adaptive servoventilation: part 1: operational algorithms. Chest 2014; 146:514.
- Galetke W, Ghassemi BM, Priegnitz C, et al. Anticyclic modulated ventilation versus continuous positive airway pressure in patients with coexisting obstructive sleep apnea and Cheyne-Stokes respiration: a randomized crossover trial. Sleep Med 2014; 15:874.
- Javaheri S, Goetting MG, Khayat R, et al. The performance of two automatic servo-ventilation devices in the treatment of central sleep apnea. Sleep 2011; 34:1693.
- Javaheri S, Harris N, Howard J, Chung E. Adaptive servoventilation for treatment of opioid-associated central sleep apnea. J Clin Sleep Med 2014; 10:637.
- Troitino A, Labedi N, Kufel T, El-Solh AA. Positive airway pressure therapy in patients with opioid-related central sleep apnea. Sleep Breath 2014; 18:367.
- Sleep Lab Titration Guide. ResMed Inc 2013. http://www.resmed.com/us/dam/documents/products/titration/s9-vpap-tx/user-guide/1013904r3_s9-vpap-tx-sleep-lab-titration_user-guide_glo_eng.pdf (Accessed on August 03, 2015).
- BIPAP AutoSV Advanced - Protocol for perdioic and complex breathing. Philips Respironics 2010. http://www.healthcare.philips.com/pwc_hc/main/homehealth/sleep/bipapautosvadvanced/downloads/BiPAPAutoSVAdvanced_Protocol.pdf (Accessed on August 03, 2015).
- Laffey JG, Kavanagh BP. Hypocapnia. N Engl J Med 2002; 347:43.
- Kuźniar TJ, Morgenthaler TI. Treatment of complex sleep apnea syndrome. Chest 2012; 142:1049.
- Cao M, Cardell CY, Willes L, et al. A novel adaptive servoventilation (ASVAuto) for the treatment of central sleep apnea associated with chronic use of opioids. J Clin Sleep Med 2014; 10:855.
- Joho S, Oda Y, Hirai T, Inoue H. Impact of sleeping position on central sleep apnea/Cheyne-Stokes respiration in patients with heart failure. Sleep Med 2010; 11:143.
- Farney RJ, Walker JM, Cloward TV, Rhondeau S. Sleep-disordered breathing associated with long-term opioid therapy. Chest 2003; 123:632.
- Allam JS, Olson EJ, Gay PC, Morgenthaler TI. Efficacy of adaptive servoventilation in treatment of complex and central sleep apnea syndromes. Chest 2007; 132:1839.
- Javaheri S, Malik A, Smith J, Chung E. Adaptive pressure support servoventilation: a novel treatment for sleep apnea associated with use of opioids. J Clin Sleep Med 2008; 4:305.
- Alattar MA, Scharf SM. Opioid-associated central sleep apnea: a case series. Sleep Breath 2009; 13:201.
- Kuźniar TJ, Kasibowska-Kuźniar K, Freedom T. Trials of bilevel positive airway pressure - spontaneous in patients with complex sleep apnoea. Pneumonol Alergol Pol 2012; 80:214.
- DIAGNOSIS AND CAUSES OF CENTRAL SLEEP APNEA (CSA)
- PRINCIPLES AND GOALS OF POSITIVE AIRWAY PRESSURE (PAP)
- General principles
- Goals of PAP titration in CSA
- Caveats of PAP titration in CSA
- PATIENTS WITH CSA AND HEART FAILURE
- Continuous positive airway pressure (CPAP)
- - Attended in-laboratory PAP titration
- - Unattended in-home "acclimation" CPAP trial
- - Other titration methods
- Multimodality titration
- PATIENTS WITH CSA AND HEART FAILURE WHO FAIL CPAP
- Patients with ejection fraction >45 percent
- - Adaptive servo-ventilation (ASV)
- Titration modules
- - Bilevel positive airway pressure (BPAP)
- Patients with ejection fraction ≤45 percent
- PATIENTS WITH CSA AND OPIOID USE
- Attended in-laboratory CPAP titration
- Attended in-laboratory ASV titration
- Attended in-laboratory BPAP titration
- PATIENTS WITH TREATMENT-EMERGENT CSA
- PATIENTS WITH RARE ETIOLOGIES OF CSA
- PATIENTS WITH CENTRAL HYPOVENTILATION SYNDROMES
- SUMMARY AND RECOMMENDATIONS